(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MYONEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MYONEX

ST13

US500000088894808

Class

35, 39

Filing

88894808

Registration

6310676

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

03/31/2026

Trademark type

Word

Nice classes

35, 39

Filing date

04/30/2020

Registration date

03/30/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/30/2021

Last transaction

03/31/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/21/2020

First use in commerce

09/21/2020

Drawing code

4

Owner type

16

Owner location

HORSHAM, PA, US

Examiner

BATT, JAIME L

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

MYONEX, LLC
MYONEX, INC.
Myers Drug Store, Inc.

Representatives

Michael J. Leonard FOX ROTHSCHILD LLP

Technical classification

Nice Classes

Class 35Class 39

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Clinical trial supply chain management servicesclinical trial drug and comparator drug sourcingmanagement of distribution centerselectronic tracking of clinical trial drugs and comparator drugs in transit for business purposesproviding transportation documentation services for others; Supply chain business management services for clinical trialsmanaging logisticsreverse logisticssupply chain servicessupply chain visibility and synchronizationsupply and demand forecasting and product distribution processes for others; business consulting services in the field of clinical trial pharmaceutical supply chain logistics

Class 39

Pharmaceutical packaging and labeling for others; Warehousing servicesstoragedistributionpick-uppackingshipping of pharmaceuticals

Publications

History of USPTO decisions and trademark events.

23 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/30/2026

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/08/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/25/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

03/30/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

02/24/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/23/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/09/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/08/2021

IUAF

USE AMENDMENT FILED

01/19/2021

EISU

TEAS STATEMENT OF USE RECEIVED

01/19/2021

DOCK

ASSIGNED TO EXAMINER

01/12/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/27/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/01/2020

PUBO

PUBLISHED FOR OPPOSITION

09/01/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/12/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/29/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

07/27/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/27/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

07/27/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/27/2020

DOCK

ASSIGNED TO EXAMINER

07/27/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/12/2020

NWAP

NEW APPLICATION ENTERED

05/04/2020

Continuous trademark protection

Get notified about every new filing that threatens MYONEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.